"Compact CRISPR Protein Enhances Gene Therapy Delivery"

Researchers at Wuhan University have developed a modified CRISPR protein, enEbCas12a, that is small enough to be packaged within an adeno-associated virus for gene therapy. This new protein shows efficient gene-editing activity and has successfully reduced cholesterol levels in mice, suggesting potential for future clinical applications.